{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:39:01Z","timestamp":1786653541648,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Non-alcoholic fatty liver disease (NAFLD) may in some cases progress to increasing grades of liver fibrosis and eventually cirrhosis. NAFLD patients often succumb to cardiovascular causes. Previous studies have linked visceral fat, a known cardiovascular risk factor, to NAFLD. Visceral fat is best quantified by measuring the waist circumference (WC). This study is aimed to determine the association of waist circumference with severity of liver fibrosis in NAFLD patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In this cross-sectional study we recruited 82 NAFLD patients diagnosed via ultrasonography. They underwent anthropometric examination followed by transient elastography with Fibro Scan to assess of liver stiffness measure (LSM). A cutoff LSM value of 7kPa was used to indicate significant fibrosis. Among the participants, 40 patients had an LSM value of &lt;7 kPa (insignificant\/no fibrosis), while 42 were found to have &gt;7 kPa (significant fibrosis). Biochemical parameters of Lipid profile and Liver enzymes were also analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis Used:<\/jats:title>\n                    <jats:p>\n                      SPSS software with Student\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -test, Chi-square\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -test, ANOVA, and Spearman correlation with 95% CI is used.\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.05 is considered significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Patients with significant fibrosis had higher mean weight (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), BMI (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.009), WC (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.002), and waist\u2013hip ratio (WHR,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.032) compared to those with no fibrosis. However, hip circumference (HC) was not significantly associated between the two groups. In correlation studies, BMI (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001), weight (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), WC (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001), and HC (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.008) positively correlated with severity of liver fibrosis in NAFLD patients. However, no significant correlation was found with WHR.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Weight, BMI, and visceral fat indicators like WC and WHR are strongly associated with liver fibrosis severity in NAFLD patients. Notably, weight, BMI, WC, and HC positively correlate with fibrosis severity, while WHR does not. Early diagnosis of fatty liver is crucial to prevent progression to life-threatening conditions like NASH or NASH cirrhosis. Waist circumference could serve as a practical screening tool in primary health care centres for identifying NAFLD patients at risk of fibrosis progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_1464_24","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T04:07:12Z","timestamp":1742789232000},"page":"1073-1078","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Waist circumference as a predictor for severity of liver fibrosis in non-alcoholic fatty liver disease patients"],"prefix":"10.4103","volume":"14","author":[{"given":"Shalini","family":"Suri","sequence":"first","affiliation":[{"name":"Department of Physiology, King George Medical University Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shraddha","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Physiology, King George Medical University Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushma Swaraj","family":"Rapelly","sequence":"additional","affiliation":[{"name":"Department of Physiology, King George Medical University Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Rungta","sequence":"additional","affiliation":[{"name":"Department of Gastromedicine, King George Medical University Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Physiology, King George Medical University Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"issue":"(Suppl)","key":"R1-20250325","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.3350\/cmh.2022.0424","article-title":"Non-alcoholic fatty liver disease:Definition and subtypes","volume":"29","author":"Han","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"R2-20250325","doi-asserted-by":"crossref","first-page":"e0237360","DOI":"10.1371\/journal.pone.0237360","article-title":"Association of worsening of nonalcoholic fatty liver disease with cardiometabolic function and intestinal bacterial overgrowth:A cross-sectional study","volume":"15","author":"Lira","year":"2020","journal-title":"PLoS One"},{"key":"R3-20250325","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1016\/j.numecd.2021.08.037","article-title":"Association between non-alcoholic fatty liver disease and impaired cardiac sympathetic\/parasympathetic balance in subjects with and without type 2 diabetes-The Cooperative Health Research in South Tyrol (CHRIS)-NAFLD sub-study","volume":"31","author":"Targher","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R4-20250325","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.3390\/ijms20092215","article-title":"Cardio-metabolic disorders in non-alcoholic fatty liver disease","volume":"20","author":"El","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R5-20250325","first-page":"108","article-title":"Recent research and insights on the disease burden of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"19","author":"Younossi","year":"2023","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"R6-20250325","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of fibrosis development in nonalcoholic steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"key":"R7-20250325","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.3390\/biomedicines9121890","article-title":"The visceral adiposity index in non-alcoholic fatty liver disease and liver fibrosis-systematic review and meta-analysis","volume":"9","author":"Ismaiel","year":"2021","journal-title":"Biomedicines"},{"key":"R8-20250325","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.3390\/diagnostics13213316","article-title":"The role of the fatty liver index (FLI) in the management of non-alcoholic fatty liver disease:A systematic review","volume":"13","author":"Biciusca","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"R9-20250325","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1159\/000514953","article-title":"NASH\/liver fibrosis prevalence and incidence of nonliver comorbidities among people with NAFLD and incidence of NAFLD by metabolic comorbidities:Lessons from South Korea","volume":"39","author":"Park","year":"2021","journal-title":"Dig Dis"},{"key":"R10-20250325","doi-asserted-by":"crossref","first-page":"10885","DOI":"10.3390\/ijms241310885","article-title":"Visceral obesity and cytokeratin-18 antigens as early biomarkers of liver damage","volume":"24","author":"de","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R11-20250325","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jceh.2015.02.006","article-title":"Non-alcoholic fatty liver disease and metabolic syndrome-position paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology","volume":"5","author":"Duseja","year":"2015","journal-title":"J Clin Exp Hepatol"},{"key":"R12-20250325","first-page":"80","article-title":"From NAFLD to cardiovascular disease. Is it (Still) the metabolic syndrome?","volume":"87","author":"Munteanu","year":"2014","journal-title":"Clujul Med"},{"key":"R13-20250325","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1136\/gut.2007.142919","article-title":"Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis","volume":"57","author":"Manco","year":"2008","journal-title":"Gut"},{"key":"R14-20250325","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.12998\/wjcc.v12.i7.1215","article-title":"Investigating the causal associations between five anthropometric indicators and nonalcoholic fatty liver disease:Mendelian randomization study","volume":"12","author":"Xiao","year":"2024","journal-title":"World J Clin Cases"},{"key":"R15-20250325","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1007\/s11695-021-05470-2","article-title":"Correlation between anthropometric measurements and non-alcoholic fatty liver disease in individuals with obesity undergoing bariatric surgery:Cross-sectional study","volume":"31","author":"Reis","year":"2021","journal-title":"Obes Surg"},{"key":"R16-20250325","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.3390\/biomedicines10102416","article-title":"Waist-to-hip ratio and inflammatory parameters are associated with risk of non-alcoholic fatty liver disease in patients with morbid obesity","volume":"10","author":"Borges-Canha","year":"2022","journal-title":"Biomedicines"},{"key":"R17-20250325","first-page":"824","article-title":"[Relationship between waist circumference trajectory and new-onset non alcoholic fatty liver disease in the non-obese population","volume":"41","author":"Wang","year":"2020","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"R18-20250325","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jceh.2021.06.008","article-title":"FibroScan-AST (FAST) score for nonalcoholic steatohepatitis-validation in an Indian Cohort","volume":"12","author":"De","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"R19-20250325","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease:State of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"key":"R20-20250325","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/MPG.0000000000003533","article-title":"Transient elastography measures of hepatic steatosis and fibrosis are associated with body composition among US adolescents","volume":"75","author":"Unalp-Arida","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R21-20250325","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s10620-007-0074-0","article-title":"Independent predictors of steatohepatitis and fibrosis in Asian Indian patients with non-alcoholic steatohepatitis","volume":"53","author":"Singh","year":"2008","journal-title":"Dig Dis Sci"},{"key":"R22-20250325","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.cgh.2021.12.034","article-title":"Low accuracy of FIB-4 and NAFLD fibrosis scores for screening for liver fibrosis in the population","volume":"20","author":"Graupera","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R23-20250325","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/00365521.2024.2305268","article-title":"The association of triglyceride-glucose-waist circumference with metabolic associated fatty liver disease and the severity of liver steatosis and fibrosis in American adults:A population-based study","volume":"59","author":"Wu","year":"2024","journal-title":"Scand J Gastroenterol"},{"key":"R24-20250325","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12876-024-03303-x","article-title":"Association between different obesity patterns and the risk of NAFLD detected by transient elastography:A cross-sectional study","volume":"24","author":"Sun","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"R25-20250325","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2741\/4892","article-title":"Current treatment paradigms and emerging therapies for NAFLD\/NASH","volume":"26","author":"Raza","year":"2021","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"Suppl 1","key":"R26-20250325","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/liv.13302","article-title":"Therapies in non-alcoholic steatohepatitis (NASH)","volume":"37","author":"Oseini","year":"2017","journal-title":"Liver Int"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1464_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:39:05Z","timestamp":1786649945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1464_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1464_24","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"2024-08-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}